Home


Home

Welcome to the Summit

The 5th annual Biomedical HIV Prevention Summit is a few weeks away and we’re excited to create an interactive and educational conference experience for attendees.  This year we are meeting virtually due to COVID-19.  The Summit will continue to highlight the role that biomedical prevention tools such as PrEP, PEP, Treatment as Prevention (TasP), and U=U have in ending the epidemic while working in the current COVID environment.

There are obvious differences between meeting in person and virtually, but we will continue to have opportunities for live engagement that allow for networking, skills-building and discussion.

  • While workshops are pre-recorded, faculty will be present to answer questions and discuss their presentations in real-time.
  • The Networking Lounge hosted in Zoom will feature facilitated discussions, health and wellness segments and music breaks.
  • Conference sponsors will be able to engage with attendees at their virtual booth. Make sure to stop by the exhibit hall.
  • Community corners are 15-minute live mini sessions featuring presentation and discussion on a particular topic related to biomedical HIV prevention.
  • Registrants will be able to chat with other attendees logged into the platform.

PLENARY SESSIONS

I Want Your Sex- PrEP and Claiming Power & Pleasure among GBMSM (hyperlink to spot on agenda page)

March 30, 12:00 pm – 1:00 pm

Alex Garner
Alex Garner, Hornet, Los Angeles, CA
David Pantalone
David Pantalone, PhD, University of Massachusetts-Boston, Boston, MA
Jose Ramon Garcia Madrid
José Ramón García Madrid, ACT Against AIDS Ambassador, Boulder, CO
Lucas A. Lara Rojas
Lucas A. Lara Rojas, Children’s Hospital Los Angeles, Center for Transyouth Health and Development in Health Services, Los Angeles, CA
Brandon Harrison
Brandon A. Harrison, Primary Care Development Corporation, Los Angeles, CA

Evolving HIV Testing as the Entry Point to HIV Prevention Sponsored by Gilead Sciences, Inc. (hyperlink to spot on agenda page)

March 30, 5:00 pm – 6:00 pm

Marlene McNeese
Marlene McNeese Assistant Director, Division of Disease Prevention and Control Houston Health Department Houston, TX
Clover Barnes
Clover Barnes, RN, BSN, MBA Bureau Chief, Integrated HIV Services Division
DC Department of Health Washington, DC
Leandro Mena
Leandro Mena, MD, MPH Professor of Infectious Diseases Director, The University of Mississippi Medical Center, Center for HIV/AIDS Research, Education and Policy

Pink Table Talk: Women’s Engagement and Inclusion with Biomedical Prevention Research (hyperlink to spot on agenda page)

March 31, 12:00 pm – 1:00 pm

Danielle Campbell
Danielle Campbell
Dr. Moupali Das, MD
Dr. Moupali Das, MD, MPH, Executive Director, Virology Therapeutic Area, Gilead Sciences
Ms. Marissa Mercado
Ms. Marissa Mercado
Dr. Kimberly Smith, MD
Dr. Kimberly Smith, MD, MPH, Head of Research and Development, ViiV Healthcare
Dr. Celeste Watkins-Hayes, PhD
Dr. Celeste Watkins-Hayes, PhD, Professor of University Diversity and Social Transformation, Jean E. Fairfax Collegiate Professor of Public Policy and Professor of Sociology at The University of Michigan

Closing Plenary: Biomedical HIV Prevention Technologies. Are Our Systems Ready?

March 31, 5:00 pm – 6:00 pm

Allysha C. Maragh-Bass, PhD
Allysha C. Maragh-Bass, PhD MPH Scientist I, FHI 360 Adjunct Professor, Duke Global Health Institute Visiting Assistant Professor, UCSF Center for AIDS Prevention Studies
Edwin Corbin-Gutierrez
Edwin Corbin-Gutierrez, Associate Director, Health Systems Integration, NASTAD, Washington, DC
Dr. Demetre C. Daskalakis, M.D., M.P.H.
Dr. Demetre C. Daskalakis, M.D., M.P.H. Director of the Division of HIV/ AIDS Prevention, Centers for Disease Control and Prevention
Latisia Grant, MPH
Latisia Grant, MPH, Senior Program Analyst, HIV, STI, & Viral Hepatitis, National Association of County and City Health Officials
Matthew Rose
Matthew Rose, Director of U.S. Policy and Advocacy Health, Global Access Project (GAP), Washington, DC